Lucentis and Biosimilar Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Lucentis (Ranibizumab) and Biosimilar
1.2 Key Market Segments
1.2.1 Lucentis (Ranibizumab) and Biosimilar Segment by Type
1.2.2 Lucentis (Ranibizumab) and Biosimilar Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Lucentis (Ranibizumab) and Biosimilar Market Overview
2.1 Global Market Overview
2.1.1 Global Lucentis (Ranibizumab) and Biosimilar Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lucentis (Ranibizumab) and Biosimilar Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Lucentis (Ranibizumab) and Biosimilar Market Competitive Landscape
3.1 Global Lucentis (Ranibizumab) and Biosimilar Sales by Manufacturers (2019-2024)
3.2 Global Lucentis (Ranibizumab) and Biosimilar Revenue Market Share by Manufacturers (2019-2024)
3.3 Lucentis (Ranibizumab) and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lucentis (Ranibizumab) and Biosimilar Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lucentis (Ranibizumab) and Biosimilar Sales Sites, Area Served, Product Type
3.6 Lucentis (Ranibizumab) and Biosimilar Market Competitive Situation and Trends
3.6.1 Lucentis (Ranibizumab) and Biosimilar Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lucentis (Ranibizumab) and Biosimilar Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Lucentis (Ranibizumab) and Biosimilar Industry Chain Analysis
4.1 Lucentis (Ranibizumab) and Biosimilar Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Lucentis (Ranibizumab) and Biosimilar Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Lucentis (Ranibizumab) and Biosimilar Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Type (2019-2024)
6.3 Global Lucentis (Ranibizumab) and Biosimilar Market Size Market Share by Type (2019-2024)
6.4 Global Lucentis (Ranibizumab) and Biosimilar Price by Type (2019-2024)
7 Lucentis (Ranibizumab) and Biosimilar Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lucentis (Ranibizumab) and Biosimilar Market Sales by Application (2019-2024)
7.3 Global Lucentis (Ranibizumab) and Biosimilar Market Size (M USD) by Application (2019-2024)
7.4 Global Lucentis (Ranibizumab) and Biosimilar Sales Growth Rate by Application (2019-2024)
8 Lucentis (Ranibizumab) and Biosimilar Market Segmentation by Region
8.1 Global Lucentis (Ranibizumab) and Biosimilar Sales by Region
8.1.1 Global Lucentis (Ranibizumab) and Biosimilar Sales by Region
8.1.2 Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Region
8.2 North America
8.2.1 North America Lucentis (Ranibizumab) and Biosimilar Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lucentis (Ranibizumab) and Biosimilar Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lucentis (Ranibizumab) and Biosimilar Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lucentis (Ranibizumab) and Biosimilar Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lucentis (Ranibizumab) and Biosimilar Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Lucentis (Ranibizumab) and Biosimilar Basic Information
9.1.2 Roche Lucentis (Ranibizumab) and Biosimilar Product Overview
9.1.3 Roche Lucentis (Ranibizumab) and Biosimilar Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Lucentis (Ranibizumab) and Biosimilar SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Coherus
9.2.1 Coherus Lucentis (Ranibizumab) and Biosimilar Basic Information
9.2.2 Coherus Lucentis (Ranibizumab) and Biosimilar Product Overview
9.2.3 Coherus Lucentis (Ranibizumab) and Biosimilar Product Market Performance
9.2.4 Coherus Business Overview
9.2.5 Coherus Lucentis (Ranibizumab) and Biosimilar SWOT Analysis
9.2.6 Coherus Recent Developments
9.3 Biogen
9.3.1 Biogen Lucentis (Ranibizumab) and Biosimilar Basic Information
9.3.2 Biogen Lucentis (Ranibizumab) and Biosimilar Product Overview
9.3.3 Biogen Lucentis (Ranibizumab) and Biosimilar Product Market Performance
9.3.4 Biogen Lucentis (Ranibizumab) and Biosimilar SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
10 Lucentis (Ranibizumab) and Biosimilar Market Forecast by Region
10.1 Global Lucentis (Ranibizumab) and Biosimilar Market Size Forecast
10.2 Global Lucentis (Ranibizumab) and Biosimilar Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Country
10.2.3 Asia Pacific Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Region
10.2.4 South America Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lucentis (Ranibizumab) and Biosimilar by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Lucentis (Ranibizumab) and Biosimilar Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lucentis (Ranibizumab) and Biosimilar by Type (2025-2030)
11.1.2 Global Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lucentis (Ranibizumab) and Biosimilar by Type (2025-2030)
11.2 Global Lucentis (Ranibizumab) and Biosimilar Market Forecast by Application (2025-2030)
11.2.1 Global Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons) Forecast by Application
11.2.2 Global Lucentis (Ranibizumab) and Biosimilar Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lucentis (Ranibizumab) and Biosimilar Market Size Comparison by Region (M USD)
Table 5. Global Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lucentis (Ranibizumab) and Biosimilar Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lucentis (Ranibizumab) and Biosimilar Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lucentis (Ranibizumab) and Biosimilar as of 2022)
Table 10. Global Market Lucentis (Ranibizumab) and Biosimilar Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lucentis (Ranibizumab) and Biosimilar Sales Sites and Area Served
Table 12. Manufacturers Lucentis (Ranibizumab) and Biosimilar Product Type
Table 13. Global Lucentis (Ranibizumab) and Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lucentis (Ranibizumab) and Biosimilar
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lucentis (Ranibizumab) and Biosimilar Market Challenges
Table 22. Global Lucentis (Ranibizumab) and Biosimilar Sales by Type (Kilotons)
Table 23. Global Lucentis (Ranibizumab) and Biosimilar Market Size by Type (M USD)
Table 24. Global Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons) by Type (2019-2024)
Table 25. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Type (2019-2024)
Table 26. Global Lucentis (Ranibizumab) and Biosimilar Market Size (M USD) by Type (2019-2024)
Table 27. Global Lucentis (Ranibizumab) and Biosimilar Market Size Share by Type (2019-2024)
Table 28. Global Lucentis (Ranibizumab) and Biosimilar Price (USD/Ton) by Type (2019-2024)
Table 29. Global Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons) by Application
Table 30. Global Lucentis (Ranibizumab) and Biosimilar Market Size by Application
Table 31. Global Lucentis (Ranibizumab) and Biosimilar Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Application (2019-2024)
Table 33. Global Lucentis (Ranibizumab) and Biosimilar Sales by Application (2019-2024) & (M USD)
Table 34. Global Lucentis (Ranibizumab) and Biosimilar Market Share by Application (2019-2024)
Table 35. Global Lucentis (Ranibizumab) and Biosimilar Sales Growth Rate by Application (2019-2024)
Table 36. Global Lucentis (Ranibizumab) and Biosimilar Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Region (2019-2024)
Table 38. North America Lucentis (Ranibizumab) and Biosimilar Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Lucentis (Ranibizumab) and Biosimilar Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Lucentis (Ranibizumab) and Biosimilar Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Lucentis (Ranibizumab) and Biosimilar Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Lucentis (Ranibizumab) and Biosimilar Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Lucentis (Ranibizumab) and Biosimilar Basic Information
Table 44. Roche Lucentis (Ranibizumab) and Biosimilar Product Overview
Table 45. Roche Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Lucentis (Ranibizumab) and Biosimilar SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Coherus Lucentis (Ranibizumab) and Biosimilar Basic Information
Table 50. Coherus Lucentis (Ranibizumab) and Biosimilar Product Overview
Table 51. Coherus Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Coherus Business Overview
Table 53. Coherus Lucentis (Ranibizumab) and Biosimilar SWOT Analysis
Table 54. Coherus Recent Developments
Table 55. Biogen Lucentis (Ranibizumab) and Biosimilar Basic Information
Table 56. Biogen Lucentis (Ranibizumab) and Biosimilar Product Overview
Table 57. Biogen Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biogen Lucentis (Ranibizumab) and Biosimilar SWOT Analysis
Table 59. Biogen Business Overview
Table 60. Biogen Recent Developments
Table 61. Global Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Global Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. North America Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. North America Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Europe Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Country (2025-2030) & (Kilotons)
Table 66. Europe Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Asia Pacific Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Region (2025-2030) & (Kilotons)
Table 68. Asia Pacific Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Region (2025-2030) & (M USD)
Table 69. South America Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Country (2025-2030) & (Kilotons)
Table 70. South America Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Country (2025-2030) & (M USD)
Table 71. Middle East and Africa Lucentis (Ranibizumab) and Biosimilar Consumption Forecast by Country (2025-2030) & (Units)
Table 72. Middle East and Africa Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Country (2025-2030) & (M USD)
Table 73. Global Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Type (2025-2030) & (Kilotons)
Table 74. Global Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Type (2025-2030) & (M USD)
Table 75. Global Lucentis (Ranibizumab) and Biosimilar Price Forecast by Type (2025-2030) & (USD/Ton)
Table 76. Global Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons) Forecast by Application (2025-2030)
Table 77. Global Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Lucentis (Ranibizumab) and Biosimilar
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lucentis (Ranibizumab) and Biosimilar Market Size (M USD), 2019-2030
Figure 5. Global Lucentis (Ranibizumab) and Biosimilar Market Size (M USD) (2019-2030)
Figure 6. Global Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lucentis (Ranibizumab) and Biosimilar Market Size by Country (M USD)
Figure 11. Lucentis (Ranibizumab) and Biosimilar Sales Share by Manufacturers in 2023
Figure 12. Global Lucentis (Ranibizumab) and Biosimilar Revenue Share by Manufacturers in 2023
Figure 13. Lucentis (Ranibizumab) and Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lucentis (Ranibizumab) and Biosimilar Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lucentis (Ranibizumab) and Biosimilar Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lucentis (Ranibizumab) and Biosimilar Market Share by Type
Figure 18. Sales Market Share of Lucentis (Ranibizumab) and Biosimilar by Type (2019-2024)
Figure 19. Sales Market Share of Lucentis (Ranibizumab) and Biosimilar by Type in 2023
Figure 20. Market Size Share of Lucentis (Ranibizumab) and Biosimilar by Type (2019-2024)
Figure 21. Market Size Market Share of Lucentis (Ranibizumab) and Biosimilar by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lucentis (Ranibizumab) and Biosimilar Market Share by Application
Figure 24. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Application (2019-2024)
Figure 25. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Application in 2023
Figure 26. Global Lucentis (Ranibizumab) and Biosimilar Market Share by Application (2019-2024)
Figure 27. Global Lucentis (Ranibizumab) and Biosimilar Market Share by Application in 2023
Figure 28. Global Lucentis (Ranibizumab) and Biosimilar Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Region (2019-2024)
Figure 30. North America Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Country in 2023
Figure 32. U.S. Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Lucentis (Ranibizumab) and Biosimilar Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Lucentis (Ranibizumab) and Biosimilar Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Country in 2023
Figure 37. Germany Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Region in 2023
Figure 44. China Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (Kilotons)
Figure 50. South America Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Country in 2023
Figure 51. Brazil Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Lucentis (Ranibizumab) and Biosimilar Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Lucentis (Ranibizumab) and Biosimilar Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Lucentis (Ranibizumab) and Biosimilar Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lucentis (Ranibizumab) and Biosimilar Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lucentis (Ranibizumab) and Biosimilar Market Share Forecast by Type (2025-2030)
Figure 65. Global Lucentis (Ranibizumab) and Biosimilar Sales Forecast by Application (2025-2030)
Figure 66. Global Lucentis (Ranibizumab) and Biosimilar Market Share Forecast by Application (2025-2030)
